Two biomarkers predict immunotherapy response for NSCLC

:

 

Two biomarkers were correlated with poor outcomes for patients with non–small cell lung cancer (NSCLC) who were treated with immune checkpoint inhibitors, according to the results of a multicenter retrospective study.

SOURCE: Mezquita L et al. Jama Oncol. 2018 Jan 11. doi: 10.1001/jamaoncol.2017.4771.

Publications

Oncology Practice CHEST Physician

Topics

Immunotherapy Lung Cancer

Article Type

News